Nanoviricides Inc (NNVC)
1.89
+0.06
(+3.28%)
USD |
NYAM |
May 10, 16:00
1.88
-0.01
(-0.53%)
After-Hours: 20:00
Nanoviricides 1 Year Total Returns (Daily): 56.20% for May 10, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 10, 2024 | 56.20% |
| May 09, 2024 | 42.97% |
| May 08, 2024 | 58.59% |
| May 07, 2024 | 38.84% |
| May 06, 2024 | 15.70% |
| May 03, 2024 | -10.32% |
| May 02, 2024 | -10.45% |
| May 01, 2024 | -13.08% |
| April 30, 2024 | -9.77% |
| April 29, 2024 | -15.04% |
| April 26, 2024 | -17.91% |
| April 25, 2024 | -14.62% |
| April 24, 2024 | -10.16% |
| April 23, 2024 | -17.09% |
| April 22, 2024 | -18.55% |
| April 19, 2024 | -20.68% |
| April 18, 2024 | -16.67% |
| April 17, 2024 | -18.49% |
| April 16, 2024 | 0.85% |
| April 15, 2024 | -1.71% |
| April 12, 2024 | 6.84% |
| April 11, 2024 | 3.25% |
| April 10, 2024 | 8.26% |
| April 09, 2024 | 1.49% |
| April 08, 2024 | 3.73% |
| Date | Value |
|---|---|
| April 05, 2024 | -15.95% |
| April 04, 2024 | -6.16% |
| April 03, 2024 | 8.58% |
| April 02, 2024 | 8.35% |
| April 01, 2024 | 10.91% |
| March 28, 2024 | -3.33% |
| March 27, 2024 | -8.87% |
| March 26, 2024 | -8.06% |
| March 25, 2024 | -8.87% |
| March 22, 2024 | -10.24% |
| March 21, 2024 | -8.80% |
| March 20, 2024 | -8.00% |
| March 19, 2024 | -11.54% |
| March 18, 2024 | -11.54% |
| March 15, 2024 | -4.00% |
| March 14, 2024 | -6.40% |
| March 13, 2024 | -11.72% |
| March 12, 2024 | -11.02% |
| March 11, 2024 | -11.81% |
| March 08, 2024 | -20.14% |
| March 07, 2024 | -18.70% |
| March 06, 2024 | -13.44% |
| March 05, 2024 | -12.32% |
| March 04, 2024 | -12.32% |
| March 01, 2024 | -3.82% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-78.07%
Minimum
Oct 14 2019
181.2%
Maximum
Jan 31 2020
-20.44%
Average
-31.19%
Median
Nov 09 2023
1 Year Total Returns (Daily) Benchmarks
| EyePoint Pharmaceuticals Inc | 80.72% |
| Enanta Pharmaceuticals Inc | -52.28% |
| GlycoMimetics Inc | -84.85% |
| FibroGen Inc | -93.48% |
| Corvus Pharmaceuticals Inc | 21.64% |